Achieve Life Sciences (ACHV) News Today $4.92 +0.04 (+0.82%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 25 at 8:00 AM | globenewswire.comAchieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024July 24 at 6:38 PM | msn.comIsrael-Hamas War Latest: Netanyahu Addresses Congress and Vows to Achieve 'Total Victory'July 23 at 4:16 AM | americanbankingnews.comAchieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above Two Hundred Day Moving Average of $4.65July 14, 2024 | marketbeat.comCVI Holdings LLC Purchases New Holdings in Achieve Life Sciences, Inc. (NASDAQ:ACHV)CVI Holdings LLC purchased a new stake in shares of Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 567,192 shares of the biopharmaceutical company's stock, valued at approximately $2,578,000July 13, 2024 | marketbeat.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) Short Interest UpdateAchieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) was the target of a significant growth in short interest during the month of June. As of June 30th, there was short interest totalling 1,520,000 shares, a growth of 35.7% from the June 15th total of 1,120,000 shares. Based on an average daily trading volume, of 218,200 shares, the short-interest ratio is currently 7.0 days.July 11, 2024 | marketbeat.comAchieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above Two Hundred Day Moving Average of $4.61Achieve Life Sciences (NASDAQ:ACHV) Stock Passes Above Two Hundred Day Moving Average of $4.61July 9, 2024 | globenewswire.comAchieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024July 3, 2024 | marketbeat.comAchieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200 Day Moving Average of $4.57Achieve Life Sciences (NASDAQ:ACHV) Shares Cross Above Two Hundred Day Moving Average of $4.57June 25, 2024 | marketbeat.comAchieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above Two Hundred Day Moving Average of $4.54Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above 200 Day Moving Average of $4.54June 15, 2024 | marketbeat.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) Short Interest Up 26.5% in MayAchieve Life Sciences, Inc. (NASDAQ:ACHV - Get Free Report) was the target of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 949,700 shares, a growth of 26.5% from the May 15th total of 750,500 shares. Based on an average trading volume of 116,100 shares, the days-to-cover ratio is currently 8.2 days.June 11, 2024 | marketbeat.comAchieve Life Sciences (NASDAQ:ACHV) Stock Passes Above 200 Day Moving Average of $4.59Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above 200-Day Moving Average of $4.59May 29, 2024 | finance.yahoo.comAchieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-CigarettesMay 25, 2024 | finance.yahoo.comAchieve Life Sciences, Inc. (ACHV)May 24, 2024 | marketbeat.comAchieve Life Sciences (NASDAQ:ACHV) Share Price Passes Above 200-Day Moving Average of $4.54Achieve Life Sciences (NASDAQ:ACHV) Stock Price Crosses Above 200-Day Moving Average of $4.54May 17, 2024 | globenewswire.comAchieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual MeetingMay 15, 2024 | marketbeat.comAnalysts Offer Predictions for Achieve Life Sciences, Inc.'s Q2 2024 Earnings (NASDAQ:ACHV)Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) - Analysts at Zacks Small Cap issued their Q2 2024 earnings per share (EPS) estimates for Achieve Life Sciences in a research report issued to clients and investors on Monday, May 13th. Zacks Small Cap analyst J. Vandermosten forecasts thatMay 14, 2024 | marketbeat.comFY2026 Earnings Estimate for Achieve Life Sciences, Inc. Issued By Zacks Small Cap (NASDAQ:ACHV)Achieve Life Sciences, Inc. (NASDAQ:ACHV - Free Report) - Investment analysts at Zacks Small Cap issued their FY2026 earnings per share (EPS) estimates for shares of Achieve Life Sciences in a report issued on Monday, May 13th. Zacks Small Cap analyst J. Vandermosten expects that the biopharmaceuMay 13, 2024 | markets.businessinsider.comBuy Rating Affirmed for Achieve Life Sciences Amid Positive Drug Development Progress and Strong Financial PositionMay 13, 2024 | marketbeat.comAchieve Life Sciences (NASDAQ:ACHV) Price Target Cut to $11.00Oppenheimer decreased their price objective on shares of Achieve Life Sciences from $18.00 to $11.00 and set an "outperform" rating for the company in a report on Monday.May 11, 2024 | markets.businessinsider.comBuy Rating Affirmed for Achieve Life Sciences on Strong Clinical Progress and Solid Financial FootingMay 10, 2024 | finance.yahoo.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2024 Earnings Call TranscriptMay 10, 2024 | finance.yahoo.comAchieve Life Sciences Inc (ACHV) Reports Q1 2024 Financial ResultsMay 9, 2024 | globenewswire.comAchieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate UpdateMay 9, 2024 | usnews.comIsraeli Defence Minister Tells 'Friends and Enemies' Israel Will Achieve War AimsMay 6, 2024 | globenewswire.comAchieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal MedicineApril 28, 2024 | latimes.comWomen Are on Track to Achieve Parity in Gender Representation Among Corporate Leadership Roles as Soon as 2030April 26, 2024 | msn.comAchieve Life Sciences files to sell 13.09M shares of common stock for holdersApril 25, 2024 | globenewswire.comAchieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024April 18, 2024 | nasdaq.comJonesTrading Initiates Coverage of Achieve Life Sciences (ACHV) with Buy RecommendationApril 17, 2024 | marketbeat.comAchieve Life Sciences (NASDAQ:ACHV) Receives New Coverage from Analysts at JonestradingJonestrading began coverage on shares of Achieve Life Sciences in a research note on Wednesday. They issued a "buy" rating and a $20.00 price target on the stock.April 17, 2024 | finance.yahoo.comAchieve Institute CEO Mark Cunningham Named to the Forbes Business CouncilApril 13, 2024 | msn.comMcNair rolls past College Achieve Paterson - Softball recapApril 11, 2024 | finance.yahoo.comAchieve Life Sciences to Present at Life Science Innovation Northwest 2024 ConferenceApril 9, 2024 | marketbeat.comAchieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200-Day Moving Average of $4.40Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above 200 Day Moving Average of $4.40April 4, 2024 | seekingalpha.comAchieve Life Sciences: An Excellent Drug Addressing A Large Market Could Drive 5x ReturnsApril 1, 2024 | finance.yahoo.comACHV: 2023 ResultsApril 1, 2024 | marketbeat.comAchieve Life Sciences (NASDAQ:ACHV) Rating Reiterated by OppenheimerOppenheimer reaffirmed an "outperform" rating and issued a $18.00 price target on shares of Achieve Life Sciences in a report on Monday.March 30, 2024 | seekingalpha.comAchieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call TranscriptMarch 29, 2024 | finance.yahoo.comQ4 2023 Achieve Life Sciences Inc Earnings CallMarch 28, 2024 | benzinga.comRecap: Achieve Life Sciences Q4 EarningsMarch 28, 2024 | finance.yahoo.comAchieve Life Sciences Inc Reports Year-End Loss, Progresses Towards FDA ApprovalMarch 28, 2024 | globenewswire.comAchieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate UpdateMarch 28, 2024 | msn.comOptions Volatility and Implied Earnings Moves Today, March 28, 2024March 27, 2024 | msn.comAchieve Life Sciences Q4 2023 Earnings PreviewMarch 21, 2024 | marketbeat.comAchieve Life Sciences (NASDAQ:ACHV) Stock Passes Above Two Hundred Day Moving Average of $4.42Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200 Day Moving Average of $4.42March 20, 2024 | finance.yahoo.comAchieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual MeetingMarch 18, 2024 | bizjournals.comOver $1 million raised for community initiatives, scholarships at Donald Driver's Driven To Achieve Awards: SlideshowMarch 16, 2024 | ca.finance.yahoo.comACHV Apr 2024 2.500 callMarch 14, 2024 | finance.yahoo.comAchieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024March 13, 2024 | marketbeat.comAchieve Life Sciences (ACHV) to Release Quarterly Earnings on ThursdayAchieve Life Sciences (NASDAQ:ACHV) will be releasing earnings on Thursday, March 14, Yahoo Finance reports. Get Achieve Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter. Email Address New trading system called MSFT, NVDA & MSFT (Ad)Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today. Just follow this link here! ACHV Media Mentions By Week ACHV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACHV News Sentiment▼0.060.62▲Average Medical News Sentiment ACHV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACHV Articles This Week▼52▲ACHV Articles Average Week Get Achieve Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: EBS News LXRX News VNDA News XOMA News CDXS News RIGL News AGEN News RGLS News VSTM News SGMO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACHV) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achieve Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Achieve Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.